Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾Ç±³Á¤¼ö¼ú¿¡ ÀÇÇÑ Æó¼â¼º ¼ö¸é ¹«È£ÈíÁõ ȯÀÚÀÇ Ä¡Çè·Ê

MAXILLARY, MANDIBULAR, AND GENIAL ADVANCEMENT FOR TREATMENT OF OBSTRUCTIVE SLEEP APNEA : A CASE REPORT

´ëÇѱ¸°­¾Ç¾È¸é¿Ü°úÇÐȸÁö 1998³â 24±Ç 4È£ p.454 ~ 460
±èÁ¤È£, ¹éÁö·É, ±èÁ¾¹è,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁ¤È£ (  ) - °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­¾Ç¾È¸é¿Ü°úÇб³½Ç
¹éÁö·É (  ) - °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­¾Ç¾È¸é¿Ü°úÇб³½Ç
±èÁ¾¹è (  ) - °è¸í´ëÇÐºÎ¼Ó µ¿»êÀÇ·á¿ø Ä¡°ú

Abstract

¼­·Ð
¼ö¸é ¹«È£Èí ÁõÈıº (sleep apnea syndrome)À̶õ ¼ö¸é Áß »óºÎ±âµµÀÇ Æó¼â·Î ÀÎÇØ ¹ß»ýÇÏ
´Â È£ÈíÁß´ÜÀÌ Æ¯Â¡À¸·Î Àú»ê¼ÒÁõ°ú ¼ö¸éºÐÀý·Î ÀÎÇØ ÄÚ°ñÀÌ, ÁÖ°£Á¹À½, ±â¾ï·Â °¨Åð, À̸¥
¾ÆħÀÇ µÎÅë, ¾Ç¸ù, ¿ì¿ïÁõ µîÀÇ ´Ù¾çÇÑ Áõ»óÀ» ³ªÅ¸³»¸ç ,¼ö¸éÁß 10ÃÊ ÀÌ»óÀÇ ¹«È£Èí »óÅÂ
°¡ 1½Ã°£¿¡ 5ȸ ¶Ç´Â 7½Ã°£ Áß 30ȸ ÀÌ»ó ¹ß»ýÇÒ ¶§·Î Á¤ÀÇÇÑ´Ù. ÀüüÀα¸ÀÇ ¾à 1-3% Á¤µµ
¿¡¼­ ¹ß»ýÇÏ°í Á߳Ⳳ¼ºÀ̳ª ºñ¸¸ÀÚ¿¡°Ô¼­ È£¹ßÇÏ¸ç ³²¼ºÀÌ ¿©¼ºº¸´Ù 10¹è Á¤µµ È£¹ßÇÑ´Ù°í
¾Ë·ÁÁ® ÀÖ´Ù.
¹«È£ÈíÁõ(apnea)Àº ¿øÀο¡ µû¶ó °¡Àå ÀϹÝÀûÀÎ ÇüÅÂÀÎ ¼ö¸éÁßÀÇ »ó±âµµ Æó¼â·Î ÀÎÇÑ Æó¼â
¼º¹«È£ÈíÁõ, °¨¼ÒµÈ È£Èí±ÙÀÇ È°µ¿¼ºÀ¸·Î ÀÎÇÑ ÁßÃß¼º¹«È£ÈíÁõ, ±×¸®°í È¥ÇÕÇü¹«È£ÈíÁõ µîÀ¸
·Î ³ª´­ ¼ö ÀÖ´Ù.
Áø´Ü¹æ¹ýÀ¸·Î´Â ÀÓ»óÀû °Ë»ç, µÎºÎ¹æ»ç¼± ±Ô°Ý»çÁø, ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ, ÀÚ±â°ø¸í»çÁø ÃÔ¿µ,
¼ö¸é´Ù¿ø°Ë»ç(polysomnography)µîÀÌ ÀÖÀ¸¸ç ÀÓ»óÀûÀ¸·Î´Â ¸ÕÀú °æÁ¦¹ß´Þ°ú ¼ÒµæÁõ°¡·Î ÀÎ
ÇÑ ¿îµ¿ºÎÁ·°ú ¿µ¾ç»óÅÂÀÇ È£Àü¿¡ µû¶ó °è¼Ó Áõ°¡Ãß¼¼¿¡ ÀÖ´Â ºñ¸¸µµ ÃøÁ¤À» ºñ·ÔÇÏ¿© ¼ö¸é
ÁßÀÇ È£ÈíÁß´ÜÀ» ¾ß±âÇÏ´Â ¸ðµç »ó±âµµºÎÀ§ÀÇ ºñÁ¤»óÀûÀÎ ÇغÎÇÐÀû ±¸Á¶µéÀ» Æò°¡ÇØ¾ß ÇÑ
´Ù.
°´°üÀûÀ¸·Î °¡Àå Áß¿äÇÑ Áø´Ü¹æ¹ýÀÎ ¼ö¸é´Ù¿ø°Ë»ç´Â ÃʱâÀÇ Áø´Ü»Ó ¾Æ´Ï¶ó Ä¡·áÀÇ ¼º°øÁ¤
µµ¸¦ Æò°¡ÇÏ´Â ±âÁØÀ¸·Îµµ »ç¿ëµÈ´Ù. º» °Ë»ç¿¡¼­´Â È£ÈíºÎÀüÁö¼ö(RDI), µ¿¸ÆÇ÷ »ê¼ÒÆ÷È­µµ
(SaO2), ³úÆÄ°Ë»ç(EEG), ½ÉÀüµµ°Ë»ç(ECG lead V2) µîÀ» Çؼ®ÇÏ°Ô µÇ´Âµ¥ È£
ÈíºÎÀüÁö¼ö°¡ 20 ÀÌ»óÀ̰ųª µ¿¸ÆÇ÷ »ê¼ÒÆ÷È­µµ°¡ 85% ÀÌÇÏ·Î ¶³¾îÁö¸é ÀÓ»óÀûÀ¸·Î Æó¼â¼º
¼ö¸é ¹«È£ÈíÁõÀ¸·Î Áø´ÜÇÏ°Ô µÈ´Ù.
Ä¡·á¹æ¹ýÀº ºñ¿Ü°úÀû ¹æ¹ý°ú ¿Ü°úÀûÀÎ ¼ö¼ú¹ýÀ¸·Î ³ª´©¾îº¼ ¼ö ÀÖ´Ù. ºñ¿Ü°úÀû ¹æ¹ýÀ¸·Î´Â
üÁßÁ¶Àý, Áö¼ÓÀû ±âµµ¾ç¾Ð, acetazolamide, protriptyline µîÀÇ ¾à¹°Ä¡·á, ¼³°ßÀα¸, head
position holding ÀåÄ¡ µîÀÌ ÀÌ¿ëµÇ°í ÀÖÀ¸¸ç, ¼ö¼úÀû ¹æ¹ýÀ¸·Î´Â ÃÊâ±â¿¡ »ç¿ëµÈ ±â°üÁöÀý
°³¼ú(tracheostomy)¸¦ ºñ·ÔÇÏ¿© ÆíµµÃ´Á¦¼ú(tonsillectomy), ¾Æµ¥³ëÀ̵å ÀýÁ¦¼ú
(adenoidectomy), ÄÚ¼ö¼ú(nasal surgery), ±¸°³¼ö±¸°³ÀεμºÇü¼ú(uvulopalatopharyngoplasty)
ÀÌ ÀÖÀ¸¸ç ÃÖ±Ù¿¡´Â ÇϾÇÀÇ Àü¹æÀ̵¿À¸·Î Çô±âÀúºÎ¸¦ Àü¹æÀ¸·Î À̵¿½ÃÅ°´Â ¾Ç±³Á¤¼ú µîÀÌ
³Î¸® »ç¿ëµÇ°í ÀÖ´Ù.
ÀÌ¿¡ ÀúÀÚ´Â ÄÚ°ñÀ̸¦ µ¿¹ÝÇÑ ½ÉÇÑ È£ÈíÀå¾Ö¸¦ ÁÖ¼Ò·Î º»¿ø À̺ñÀÎÈÄ°ú¿¡¼­ ÀÇ·ÚµÈ È¯ÀÚ¿¡
°Ô ¼ö¸é´Ù¿ø°Ë»ç¸¦ ½ÃÇàÇÑ °á°ú ½ÉÇÑ ¼ö¸é ¹«È£ÈíÁõÀ¸·Î ³ªÅ¸³ª ÀÏÂ÷ÀûÀ¸·Î hyoid
myotomy ¹× suspension ¾øÀÌ ¾Ç±³Á¤¼ö¼ú¸¸À¸·Î ¾çÈ£ÇÑ °á°ú¸¦ ¾ò¾ú±â¿¡ º¸°íÇÏ´Â ¹ÙÀÌ´Ù.
#ÃÊ·Ï#
Obstructive sleep apnea syndrome (OSAS) is characterized by repeated collapse of the
upper airway, producing hypopnea, apnea, and ultimately, oxygen desaturation of
hemoglobin.
The major characteristics of OSAS are male predominace, obesity, hypersomnolence,
and excessive snoring. Patients suffer deterioration of memory and judgement,
irritability, morning headache, sexual dysfunction, and personality changes. Psychologic
changes involving the cardiopulmonary system occur and may lead to life-threatening
events.
The presurgical evaluation includes nocturnal polysomnography, clinical examination,
radiologic evaluation, and fiberoptic endoscopy.
The current surgical procedures used for OSAS are tracheostomy, tonsillectomy,
adenoidectomy, nasal surgery (septoplasty, partial turbinectomy), tongue reduction,
uvulopalatopharyngoplasty (UPPP), anterior sagittal osteotomy of the mandible with
hyoid myotomy and suspension, and maxillary, mandibular and hyoid advancement.
Selection of the surgical procedure is based upon the severity of the sleep apnea,
presence of a skeletal deficiency, presence of morbid obesity, and anatomic site of the
obstructive process.
Patient with OSAS documented by polysomnography, was evaluated by cephalometric
analysis, and polysomnography before and 6 months following the surgical procedure.
Patient underwent maxillary, mandibular osteotomies via Lefort I, SSRO, and
genioplasty.

obstructive sleep apnea syndrome(OSAS); polysomnography; maxillary; mandibular and genial advancement;

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed